文献速递肿瘤 PET/CT核素与放射性配体治疗

99mTc-MIP-1404 PSMA在前列腺腺癌孤立性气管旁淋巴结中的摄取

The 99mTc-MIP-1404 PSMA Uptake in the Isolated Paratracheal Lymph Node From the Prostate Adenocarcinoma.
PubMed 文献 · Clin Nucl Med · 2022-09-06

一名56岁男性因前列腺特异性抗原筛查结果异常(33 ng/mL)就诊,确诊为低分化前列腺腺癌,Gleason评分9(5+4)。99mTc-MIP-1404 PSMA SPECT/CT显示前列腺、盆腔髂外及闭孔淋巴结、腹主动脉旁及右侧下气管旁间隙存在PSMA阳性病灶。患者接受雄激素剥夺治疗及多西他赛早期化疗(6个周期),随后计划对前列腺和精囊进行放疗。

要点

  • 56岁男性,PSA 33 ng/mL,确诊Gleason评分9(5+4)低分化前列腺腺癌。
  • 99mTc-MIP-1404 PSMA SPECT/CT检出前列腺、盆腔淋巴结、腹主动脉旁及右侧下气管旁间隙PSMA阳性病灶。
  • 患者接受雄激素剥夺治疗和多西他赛化疗(6个周期),后续计划前列腺及精囊放疗。

核心结论

  • 99mTc-MIP-1404 PSMA SPECT/CT可检出前列腺腺癌包括孤立性右侧下气管旁淋巴结在内的多部位PSMA阳性病灶。

研究设计与样本

  • 本文为病例报告,报道一名56岁男性前列腺腺癌患者的99mTc-MIP-1404 PSMA SPECT/CT显像及治疗经过。

主要发现

  • 患者筛查时前列腺特异性抗原水平为33 ng/mL,确诊为低分化前列腺腺癌,Gleason评分9(5+4)。
  • 99mTc-MIP-1404 PSMA SPECT/CT显示前列腺、盆腔髂外及闭孔淋巴结、腹主动脉旁和右侧下气管旁间隙存在99mTc-PSMA阳性病灶。

临床怎么用

  • 患者接受雄激素剥夺治疗和多西他赛早期化疗(6个周期),之后计划对前列腺和精囊进行放疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The oncologist consulted a 56-year-old man after receiving prostate-specific antigen screening results. Prostate-specific antigen level during the screen time was 33 ng/mL. As a result, poorly differentiated prostate adenocarcinoma with a Gleason score of 9 (5 + 4) was diagnosed. SPECT/CT scan with 99mTc-MIP-1404 PSMA tracer was performed. The 99mTc-PSMA-positive lesions were detected in the prostate, external iliac, obturator lymph nodes of the pelvis, para-aortic, and the right lower paratracheal space. The patient was prescribed androgen deprivation therapy and early chemotherapy with docetaxel (6 fractions), after which radiation therapy to prostate and seminal vesicles was planned.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Jonusas J, Tiskevicius S, Janulionis E, et al. The 99mTc-MIP-1404 PSMA Uptake in the Isolated Paratracheal Lymph Node From the Prostate Adenocarcinoma. Clin Nucl Med. 2022. PMID: 36342797. doi:10.1097/RLU.0000000000004384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。